Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Papillary thyroid carcinoma with bone formation

Authors
Na, Ki YongKim, Hyun-SookLee, Seung KwanJung, Woon-WonSung, Ji-YounKim, Youn WhaPark, Yong-Koo
Issue Date
2013
Publisher
ELSEVIER GMBH, URBAN & FISCHER VERLAG
Keywords
Papillary thyroid carcinoma; BMP-9; ALK1; Bone formation
Citation
PATHOLOGY RESEARCH AND PRACTICE, v.209, no.1, pp.14 - 18
Indexed
SCIE
SCOPUS
Journal Title
PATHOLOGY RESEARCH AND PRACTICE
Volume
209
Number
1
Start Page
14
End Page
18
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/106394
DOI
10.1016/j.prp.2012.10.001
ISSN
0344-0338
Abstract
Bone formation is a rarely encountered finding during histological examination of papillary thyroid carcinoma (PTC). This study aimed to analyze clinicopathological parameters in patients with PTC showing bone formation, to document histological features of bone formation in PTC, and to investigate osteogenic proteins. Bone morphogenic protein (BMP)-9 is known as the most potent osteoinductive protein of the BMP subtypes. Recent research suggests that the activin receptor-like kinase (ALK) 1 is an essential cellular receptor that mediates BMP-9-induced osteogenic signaling. A retrospective review of tumor sections from 567 patients with a diagnosis of PTC was performed. Using immunohistochemistry and quantitative real-time polymerase chain reaction, we investigated the expression of ALK1 and BMP-9 in normal thyroid tissue and PTC samples with and without bone formation. Bone formation was found in 13% of patients with PTC. A significant association was seen between bone formation and old age. BMP-9 expression in tumors was increased compared to that in normal thyroid tissues. BMP-9 expression in tumors with bone formation was not significantly different from that in tumors without bone formation. ALK1 expression in tumors with bone formation was increased compared to that in normal thyroid tissue and tumors without bone formation. Our study suggests that upregulation of ALK1 might be an underlying molecular mechanism that explains osteogenesis in PTC. (C) 2012 Elsevier GmbH. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Health Sciences > School of Health and Environmental Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE